Stablix, Inc.
生物技术
New York，NY 2,093 位关注者
Transformative medicines for targeted deubiquitination therapeutics
关于我们
Stablix is pioneering an entirely new field of targeted deubiquitination therapeutics (TDT) to bring transformative medicines to patients with unmet medical need. Co-located in New York City and Boston, we are a creative and multidisciplinary team of scientists, innovators and leaders dedicated to changing the way we approach drug development by establishing a powerful small-molecule modality for a wide variety of devastating diseases.
- 网站
-
https://www.stablix.com
Stablix, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- New York，NY
- 类型
- 私人持股